| D007035 |
Hypothermia |
Lower than normal body temperature, especially in warm-blooded animals. |
Hypothermia, Accidental,Accidental Hypothermia,Accidental Hypothermias,Hypothermias,Hypothermias, Accidental |
|
| D007036 |
Hypothermia, Induced |
Abnormally low BODY TEMPERATURE that is intentionally induced in warm-blooded animals by artificial means. In humans, mild or moderate hypothermia has been used to reduce tissue damages, particularly after cardiac or spinal cord injuries and during subsequent surgeries. |
Induced Hypothermia,Mild Hypothermia, Induced,Moderate Hypothermia, Induced,Targeted Temperature Management,Therapeutic Hypothermia,Hypothermia, Therapeutic,Induced Mild Hypothermia,Induced Mild Hypothermias,Induced Moderate Hypothermia,Induced Moderate Hypothermias,Mild Hypothermias, Induced,Moderate Hypothermias, Induced,Targeted Temperature Managements |
|
| D007388 |
Internal Medicine |
A medical specialty concerned with the diagnosis and treatment of diseases of the internal organ systems of adults. |
General Internal Medicine,Medicine, Internal,Internal Medicine, General,Medicine, General Internal |
|
| D007849 |
Laurence-Moon Syndrome |
An autosomal recessive condition characterized by hypogonadism; spinocerebellar degeneration; MENTAL RETARDATION; RETINITIS PIGMENTOSA; and OBESITY. This syndrome was previously referred to as Laurence-Moon-Biedl syndrome until BARDET-BIEDL SYNDROME was identified as a distinct entity. (From N Engl J Med. 1989 Oct 12;321(15):1002-9) |
Laurence-Moon-Biedl Syndrome,Laurence Moon Biedl Syndrome,Laurence Moon Syndrome,Syndrome, Laurence-Moon,Syndrome, Laurence-Moon-Biedl |
|
| D008064 |
Lipidoses |
Conditions characterized by abnormal lipid deposition due to disturbance in lipid metabolism, such as hereditary diseases involving lysosomal enzymes required for lipid breakdown. They are classified either by the enzyme defect or by the type of lipid involved. |
Lipidosis,Lipoidosis |
|
| D010600 |
Pharmacology |
The study of the origin, nature, properties, and actions of drugs and their effects on living organisms. |
Pharmacologies |
|
| D011041 |
Poisoning |
A condition or physical state produced by the ingestion, injection, inhalation of or exposure to a deleterious agent. |
Poisonings |
|
| D001775 |
Blood Circulation |
The movement of the BLOOD as it is pumped through the CARDIOVASCULAR SYSTEM. |
Blood Flow,Circulation, Blood,Blood Flows,Flow, Blood |
|
| D002738 |
Chloroquine |
The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses. |
Aralen,Arechine,Arequin,Chingamin,Chlorochin,Chloroquine Sulfate,Chloroquine Sulphate,Khingamin,Nivaquine,Sulfate, Chloroquine,Sulphate, Chloroquine |
|
| D003930 |
Diabetic Retinopathy |
Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION. |
Diabetic Retinopathies,Retinopathies, Diabetic,Retinopathy, Diabetic |
|